(Q36850343)

16 August 2017

1 reference

title

Drospirenone, a new progestogen, for postmenopausal women with hypertension (English)

1 reference

16 August 2017

Madhavi Mallareddy

1

1 reference

16 August 2017

Vladimir Hanes

series ordinal

2

1 reference

16 August 2017

William B White

series ordinal

3

1 reference

16 August 2017

publication date

1 January 2007

1 reference

16 August 2017

1 reference

16 August 2017

volume

24

1 reference

16 August 2017

issue

6

1 reference

16 August 2017

page(s)

453-466

1 reference

Prevalence of Hypertension in the US Adult Population : Results From the Third National Health and Nutrition Examination Survey, 1988-1991

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200724060-00002

Hypertension and its treatment in postmenopausal women: baseline data from the Women's Health Initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200724060-00002

Gender differences in the regulation of blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200724060-00002

Postmenopausal hormone therapy increases risk for venous thromboembolic disease. The Heart and Estrogen/progestin Replacement Study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200724060-00002

A comparative investigation of contraceptive reliability, cycle control and tolerance of two monophasic oral contraceptives containing either drospirenone or desogestrel

21 January 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/17571911

12 December 2020

Insulin resistance and sympathetic overactivity in women

1 reference

https://pubmed.ncbi.nlm.nih.gov/17571911

12 December 2020

Safety and efficacy of drospirenone used in a continuous combination with 17beta-estradiol for prevention of postmenopausal osteoporosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17571911

12 December 2020

The influence of menopause on blood pressure

1 reference

https://pubmed.ncbi.nlm.nih.gov/17571911

12 December 2020

Estradiol and drospirenone for climacteric symptoms in postmenopausal women: a double-blind, randomized, placebo-controlled study of the safety and efficacy of three dose regimens

1 reference

https://pubmed.ncbi.nlm.nih.gov/17571911

12 December 2020

The emergence of the metabolic syndrome with menopause

1 reference

https://pubmed.ncbi.nlm.nih.gov/17571911

12 December 2020

Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17571911

12 December 2020

Menopausal obesity--myth or fact?

1 reference

https://pubmed.ncbi.nlm.nih.gov/17571911

12 December 2020

Use of menopausal hormones in the United States, 1992 through June, 2003.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17571911

12 December 2020

Cardiovascular protection and blood pressure reduction: a meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17571911

12 December 2020

1 reference

https://pubmed.ncbi.nlm.nih.gov/17571911

12 December 2020

Conception and pharmacodynamic profile of drospirenone

1 reference

https://pubmed.ncbi.nlm.nih.gov/17571911

12 December 2020

Effects of a New Hormone Therapy, Drospirenone and 17-β-Estradiol, in Postmenopausal Women With Hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/17571911

12 December 2020

Recommendations for estrogen and progestogen use in peri-and postmenopausal women: October 2004 position statement of The North American Menopause Society

1 reference

https://pubmed.ncbi.nlm.nih.gov/17571911

12 December 2020

Climacteric medicine: European Menopause and Andropause Society (EMAS) 2004/2005 position statements on peri- and postmenopausal hormone replacement therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/17571911

12 December 2020

Efficacy and tolerability of a monophasic oral contraceptive containing ethinylestradiol and drospirenone

1 reference

https://pubmed.ncbi.nlm.nih.gov/17571911

12 December 2020

Drospirenone: pharmacology and pharmacokinetics of a unique progestogen

1 reference

https://pubmed.ncbi.nlm.nih.gov/17571911

12 December 2020

Long-term safety of drospirenone-estradiol for hormone therapy: a randomized, double-blind, multicenter trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/17571911

12 December 2020

Progestogens with antimineralocorticoid activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/17571911

12 December 2020

Dihydrospirorenone, a new progestogen with antimineralocorticoid activity: effects on ovulation, electrolyte excretion, and the renin-aldosterone system in normal women.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17571911

12 December 2020

The Framingham Study: historical insight on the impact of cardiovascular risk factors in men versus women.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17571911

12 December 2020

Dihydrospirorenone (ZK30595): a novel synthetic progestagen--characterization of binding to different receptor proteins

1 reference

https://pubmed.ncbi.nlm.nih.gov/17571911

12 December 2020

Novel mechanisms responsible for postmenopausal hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/17571911

12 December 2020

The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17571911

12 December 2020

Sex hormones as potential modulators of vascular function in hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/17571911

12 December 2020

Assessment of the novel selective aldosterone blocker eplerenone using ambulatory and clinical blood pressure in patients with systemic hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/17571911

12 December 2020

Conventional and ambulatory blood pressure and menopause in a prospective population study

1 reference

https://pubmed.ncbi.nlm.nih.gov/17571911

12 December 2020

Metabolic syndrome throughout the menopausal transition: influence of age and menopausal status.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17571911

12 December 2020

Randomized, placebo-controlled trial of the effects of drospirenone-estradiol on blood pressure and potassium balance in hypertensive postmenopausal women receiving hydrochlorothiazide

1 reference

https://pubmed.ncbi.nlm.nih.gov/17571911

12 December 2020

The demography of menopause

1 reference

https://pubmed.ncbi.nlm.nih.gov/17571911

12 December 2020

Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/17571911

12 December 2020

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/17571911

12 December 2020

Influence of menopause on serum lipids and lipoproteins

1 reference

https://pubmed.ncbi.nlm.nih.gov/17571911

12 December 2020

Effects of a new oral contraceptive containing an antimineralocorticoid progestogen, drospirenone, on the renin-aldosterone system, body weight, blood pressure, glucose tolerance, and lipid metabolism

1 reference

https://pubmed.ncbi.nlm.nih.gov/17571911

12 December 2020

Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies

1 reference

https://pubmed.ncbi.nlm.nih.gov/17571911

12 December 2020

Effects of estrogens and progestogens on the renin-aldosterone system and blood pressure

1 reference

https://pubmed.ncbi.nlm.nih.gov/17571911

12 December 2020

Salt sensitivity and hypertension after menopause: role of nitric oxide and angiotensin II.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17571911

12 December 2020

Postmenopausal hormone replacement therapy and venous thromboembolism.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17571911

12 December 2020

Additive effect of drospirenone/17-beta-estradiol in hypertensive postmenopausal women receiving enalapril

1 reference

https://pubmed.ncbi.nlm.nih.gov/17571911

12 December 2020

Antihypertensive effects of drospirenone with 17beta-estradiol, a novel hormone treatment in postmenopausal women with stage 1 hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/17571911

12 December 2020

Inhibition of ovulation by a novel progestogen (drospirenone) alone or in combination with ethinylestradiol

1 reference

https://pubmed.ncbi.nlm.nih.gov/17571911

12 December 2020

Medroxyprogesterone Acetate But Not Drospirenone Ablates the Protective Function of 17β-Estradiol in Aldosterone Salt-Treated Rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/17571911

12 December 2020

Unopposed estrogen therapy and the risk of invasive breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17571911

12 December 2020

The challenge of controlling systolic blood pressure: data from the National Health and Nutrition Examination Survey (NHANES III), 1988--1994.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17571911

12 December 2020

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

1 reference

https://pubmed.ncbi.nlm.nih.gov/17571911

12 December 2020

Drospirenone: a novel progestogen with antimineralocorticoid and antiandrogenic activity. Pharmacological characterization in animal models.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17571911

12 December 2020

Effects of drospirenone/17-beta estradiol on blood pressure and potassium balance in hypertensive postmenopausal women

1 reference

https://pubmed.ncbi.nlm.nih.gov/17571911

12 December 2020

Effect of drospirenone on serum potassium and drospirenone pharmacokinetics in women with normal or impaired renal function.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17571911

12 December 2020

Effect of an oral contraceptive containing drospirenone and ethinylestradiol on general well-being and fluid-related symptoms.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17571911

12 December 2020

Drospirenone: a novel progestogen with antimineralocorticoid and antiandrogenic activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/17571911

12 December 2020

Lack of placebo effect on ambulatory blood pressure

1 reference

https://pubmed.ncbi.nlm.nih.gov/17571911

12 December 2020

10.2165/00002512-200724060-00002

Identifiers

DOI

1 reference

Dimensions Publication ID

16 August 2017

1040305076

0 references

1 reference